Differential effects of a selective dopamine D1-like receptor agonist on motor activity and c-fos expression in the frontal-striatal circuitry of SHR and Wistar-Kyoto rats

Behavioral and Brain Functions

Volumn 2, Issue , 2006, Pages

  Diaz Heijtz, Rochellys ^a,b   Castellanos, F Xavier ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; MESSENGER RNA; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; CINGULATE GYRUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; INSULA; LOCOMOTION; MALE; MOTOR ACTIVITY; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRIFORM CORTEX; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 33746583518     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-2-18     Document Type: Article

References (41)

1. Castellanos FX, Tannock R: Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002, 3:617-628.
2. Volkow ND, Wang GJ, Fowler JS, Ding YS: Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1410-1415.
3. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P: Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1313-1323.
4. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG: Dopamine receptors: from structure to function. Physiol Rev 1998, 78:189-225.
5. Arnsten AF, Li BM: Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 2005, 57:1377-1384.
6. Chudasama Y, Robbins TW: Functions of frontostriatal systems in cognition: Comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol 2006.
7. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK, Clasen LS, Sharp WS, Inoff-Germain G, Wavrant-De VF, rcos-Burgos M, Straub RE, Hardy JA, Castellanos FX, Rapoport JL: Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet 2005, 134:67-72.
8. Misener VL, Luca P, Azeke O, Crosbie J, Waldman I, Tannock R, Roberts W, Malone M, Schachar R, Ickowicz A, Kennedy JL, Barr CL: Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder. Mol Psychiatry 2004, 9:500-509.
9. Laurin N, Misener VL, Crosbie J, Ickowicz A, Pathare T, Roberts W, Malone M, Tannock R, Schachar R, Kennedy JL, Barr CL: Association of the calcyon gene (DRDIIP) with attention deficit/hyperactivity disorder. Mol Psychiatry 2005, 10:1117-1125.
10. Papa M, Diewald L, Carey MP, Esposito FJ, Gironi Carnevale UA, Sadile AG: A rostro-caudal dissociation in the dorsal and ventral striatum of the juvenile SHR suggests an anterior hypo- and a posterior hyperfunctioning mesocorticolimbic system. Behav Brain Res 2002, 130:171-179.
11. Kirouac GJ, Ganguly PK: Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis. Neuroscience 1993, 52:135-141.
12. Watanabe Y, Fujita M, Ito Y, Okada T, Kusuoka H, Nishimura T: Brain dopamine transporter in spontaneously hypertensive rats. J Nucl Med 1997, 38:470-474.
13. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M: Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1239-1247.
14. Ruskin DN, Rawji SS, Walters JR: Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393. J Pharmacol Exp Ther 1998, 286:272-281.
15. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S: Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 1994, 79:729-742.
16. Waddington JL, O'Tuathaigh C, O'sullivan G, Tomiyama K, Koshikawa N, Croke DT: Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface. Psychopharmacology (Berl) 2005, 181:611-638.
17. Johansson IM, Wester P, Hakova M, Gu W, Seckl JR, Olsson T: Early and delayed induction of immediate early gene expression in a novel focal cerebral ischemia model in the rat. Eur J Neurosci. 2000, 12:3615-3625.
18. Abrahams BS, Rutherford JD, Mallet PE, Beninger RJ: Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434. Eur J Pharmacol 1998, 343:111-118.
19. Cohen C, Perrault G, Sanger DJ: Effects of D1 dopamine receptor agonists on oral ethanol self-administration in rats: comparison with their efficacy to produce grooming and hyperactivity. Psychopharmacology (Berl) 1999, 142:102-110.
20. Molloy AG, Waddington JL: Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacology (Berl) 1984, 82:409-410.
21. Salmi P, Ahlenius S: Sedative effects of the dopamine D1 receptor agonist A 68930 on rat open-field behavior. Neuroreport 2000, 11:1269-1272.
22. Diaz Heijtz R, Beraki S, Scott L, Aperia A, Forssberg H: Sex differences in the motor inhibitory and stimulatory role of dopamine D1 receptors in rats. Eur J Pharmacol 2002, 445:97-104.
23. Diaz Heijtz R, Scott L, Forssberg H: Alteration of dopamine D1 receptor-mediated motor inhibition and stimulation during development in rats is associated with distinct patterns of c-fos mRNA expression in the frontal-striatal circuitry. Eur J Neurosci 2004, 19:945-956.
24. Isacson R, Kull B, Wahlestedt C, Salmi P: A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex? Neuroscience 2004, 124:33-42.
25. Mogenson GJ, Jones DL, Yim CY: From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 1980, 14:69-97.
26. Wang JQ, McGinty JF: Scopolamine augments c-fos and zip/268 messenger RNA expression induced by the full D(1) dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience 1996, 72:601-616.
27. Dreher JK, Jackson DM: Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Res 1989, 487:267-277.
28. Moratalla R, Xu M, Tonegawa S, Graybiel AM: Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc Natl Acad Sci U S A 1996, 93:14928-14933.
29. Russell VA, Sagvolden T, Johansen EB: Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct 2005, 1:9.
30. Zhuang X, Belluscio L, Hen R: G(olf)alpha mediates dopamine D1 receptor signaling. J Neurosci 2000, 20:RC91.
31. Lezcano N, Bergson C: D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons. J Neurophysiol 2002, 87:2167-2175.
32. Lezcano N, Mrzljak L, Eubanks S, Levenson R, Goldman-Rakic P, Bergson C: Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Science 2000, 287:1660-1664.
33. Lidow MS, Roberts A, Zhang L, Koh PO, Lezcano N, Bergson C: Receptor crosstalk protein, calcyon, regulates affinity state of dopamine D1 receptors. Eur J Pharmacol 2001, 427:187-193.
34. Zelenin S, Aperia A, Diaz Heijtz R: Calcyon in the rat brain: cloning of cDNA and expression of mRNA. J Comp Neurol 2002, 446:37-45.
35. Cromwell HC, Berridge KC: Implementation of action sequences by a neostriatal site: a lesion mapping study of grooming syntax. J Neurosci 1996, 16:3444-3458.
36. Linthorst AC, Broekhoven MH, de JW, Van Wimersma Greidanus TB, Versteeg DH: Effect of SCH 23390 and quinpirole on novelty-induced grooming behaviour in spontaneously hypertensive rats and Wistar-Kyoto rats. Eur J Pharmacol 1992, 219:23-28.
37. Fujita S, Adachi K, Lee J, Uchida T, Koshikawa N, Cools AR: Decreased postsynaptic dopaminergic and cholinergic functions in the ventrolateral striatum of spontaneously hypertensive rat. Eur J Pharmacol 2004, 484:75-82.
38. Fujita S, Okutsu H, Yamaguchi H, Nakamura S, Adachi K, Saigusa T, Koshikawa N: Altered pre- and postsynaptic dopamine receptor functions in spontaneously hypertensive rat: an animal model of attention-deficit hyperactivity disorder. J Oral Sci 2003, 45:75-83.
39. Fuller RW, Hemrick-Luecke SK, Wong DT, Pearson D, Threlkeld PG, Hynes MDIII: Altered behavioral response to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats. J Pharmacol Exp Ther 1983, 227:354-359.
40. Grillner S, Markram H, De SE, Silberberg G, LeBeau FE: Microcircuits in action - from CPGs to neocortex. Trends Neurosci 2005, 28:525-533.
41. Sagvolden T, Johansen EB, Aase H, Russell VA: A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 2005, 28:397-419.